1446338-13-1

Basic information

• Product Name: N-[4-(3-methylbutoxy)-2-nitrophenyl]-2-(3-methoxyphenoxy)acetamide
• Synonyms: N-[4-(3-methylbutoxy)-2-nitrophenyl]-2-(3-methoxyphenoxy)acetamide
• CAS NO: 1446338-13-1
• Molecular Weight: 388.42
• Mol File: 1446338-13-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[4-(3-methylbutoxy)-2-nitrophenyl]-2-(3-methoxyphenoxy)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[4-(3-methylbutoxy)-2-nitrophenyl]-2-(3-methoxyphenoxy)acetamide(1446338-13-1)
• EPA Substance Registry System: N-[4-(3-methylbutoxy)-2-nitrophenyl]-2-(3-methoxyphenoxy)acetamide(1446338-13-1)

Safety Data

• Hazardous Substances Data: 1446338-13-1(Hazardous Substances Data)

Upstream product

• 107-82-4 i-pentyl bromide 
• 2088-24-6 3-methoxyphenoxyacetic acid 
• 106967-74-2 2-(3-methoxyphenoxy)acetyl chloride 
• 610-81-1 4-hydroxy-2-nitroaniline 

Downstream Products

• 1446338-14-2 N-[2-amino-4-(3-methylbutoxy)phenyl]-2-(3-methoxyphenoxy)acetamide 
• 1446338-15-3 N-[2-(isobutylamino)-4-(3-methylbutoxy)phenyl]-2-(3-methoxyphenoxy)acetamide 
• 1446337-66-1 1-isobutyl-2-(3-methoxyphenoxymethyl)-6-(3-methylbutoxy)-1H-benzimidazole 

Relevant articles and documents

BENZIMIDAZOLE DERIVATIVES AS SELECTIVE BLOCKERS OF PERSISTENT SODIUM CURRENT

The present invention is directed to a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein R, R1, R2, R3, R4, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.